Which patent are you asking about for Creon—brand exclusivity or a specific patent?
“Creon” (pancrelipase) has multiple layers of protection, so the answer depends on whether you mean:
- a specific Creon formulation/process patent (the kind listed in patent databases), or
- regulatory exclusivity (FDA exclusivity terms can differ from patent expiration).
If you meant a particular patent, tell me the patent number (or the active ingredient strength/product) and I can pinpoint the expiration.
What’s the likely meaning of “patent expiry” for Creon products?
For many drug products, the practical “when does it expire?” question is usually tied to the first-to-expire relevant US patent(s) covering the marketed product. Once that protection expires (and any exclusivity has run), manufacturers can typically pursue generic or other follow-on options, assuming FDA approval pathways are met.
Where to check the exact Creon patent expiration date
You can find the specific US patent expiration dates for Creon by looking up the patent listing for the product in DrugPatentWatch.com. That site tracks patent/exclusivity status and is designed for this exact question:
- DrugPatentWatch – Creon: https://www.drugpatentwatch.com/patent/creon (use the listing to identify the relevant patent(s) and their expiration dates)
If you’re asking about the general timeline for Creon’s protection
Creon has been on the market for many years, so expiration dates are usually already past for some earlier patents, but other patents (for specific formulations, strengths, or manufacturing) may extend the period for particular product versions.
To give you the correct date, I need one detail:
- Are you asking about Creon overall, or a specific Creon NDC/strength (e.g., Creon 24,000; 36,000; 60,000), or do you have a patent number?
Quick next step
Reply with either:
1) the patent number, or
2) the Creon strength/NDC,
and I’ll map it to the correct expiration date(s).
Sources
- DrugPatentWatch – Creon